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Objective: Important recent data on retrievable inferior vena cava filter (R-IVCF) used in civilian trauma centers suffer
from poor follow-up in these transient patients. Because US military casualties can be more easily followed globally, our
objective was to further characterize R-IVCF outcomes in a trauma population with improved follow-up.
Methods: From July 2003 to June 2007, trauma registry records were retrospectively reviewed for US soldiers injured in
Iraq and Afghanistan who had R-IVCF placement. Indications, type of filter, complications, outcomes, and retrieval data
were analyzed.
Results: Seventy-two R-IVCFs were placed during the study period. Mean follow-up was 28.0  12.0 months, in 61
(85%) patients. Mean injury severity score (ISS) was 36.3  10.4 and mean patient age was 27.4  6.4 years. Fifty-nine
R-IVCFs (82%) were not retrieved due to: death (1, 1.3%), technical failure (2, 2.8%), lost to follow-up (11, 15.2%), or
contraindications to retrieval (45, 62.5%). Thirteen R-IVCFs were successfully removed, an overall retrieval rate of 18%.
Median dwell time of those removed was 47 days (range, 10-94). IVCF indications were prophylactic in 23 (32%) and
therapeutic in 49 (68%) cases. Both retrieval failures were due to incorporation into the caval wall, attempted at 90 and
156 days. Deep vein thromboses at the insertion site or pulmonary embolism following R-IVCF placement or removal
were not observed. To date, there have been no reports of IVC stenosis or occlusion.
Conclusion: R-IVCFs were safely and effectively used in severely injured military trauma patients with high ISS. Despite
improved follow-up, overall retrieval remained low, reflecting the civilian experience. Indication, rather than follow-up
losses, accounted for the low retrieval rate. Practice patterns for R-IVCF in trauma may need to be re-examined to
optimize outcomes. (J Vasc Surg 2009;49:410-6.)The retrievable inferior vena cava filter (R-IVCF) has
become an attractive option in preventing potentially fatal
pulmonary embolism (PE) in select high-risk trauma pa-
tients. For those in whom traditional mechanical or medical
prophylaxis cannot be adequately implemented, or in
whom anticoagulation is contraindicated, R-IVCFs are
conceptually appealing. They can provide protection dur-
ing a relatively short risk period, and later be removed to
avoid potential long-term filter complications.
Outcomes data to support R-IVCF use in trauma are
limited to retrospective reviews that show encouraging
results with regards to their efficacy and short-term com-
plication profile.1-9 However, surgeons have become in-
creasingly concerned over the low overall retrieval rates of
From the Department of Surgery, Peripheral Vascular Surgery Service, Walter
ReedArmyMedical Center,a and theNormanM.RichDepartment of Surgery,
Division of Vascular Surgery, Uniformed Services University.b
Investigation performed atWalter Reed ArmyMedical Center, Washington, DC.
Competition of interest: none.
Presented at the Annual Meeting of the Society for Vascular Surgery, San
Diego, Calif, Jun 5-8, 2008.
Disclaimer:Theopinionsandassertionscontainedhereinare theprivateviewsof the
authors and are not to be construed as official or as reflecting the views of the
United States Army or theDepartment ofDefense. All authors are employees of
the United States government.
Reprint requests: Owen N. Johnson, III, MD, CPT, MC, USA, Depart-
ment of Surgery, Walter Reed Army Medical Center, 6900 Georgia
Avenue, NW, Building 2, Ward 5C, Washington, DC 20307 (e-mail:
Owen.Johnson@amedd.army.mil).
CME article
0741-5214/$36.00
Copyright © 2009 Published by Elsevier Inc. on behalf of The Society for
Vascular Surgery.doi:10.1016/j.jvs.2008.09.004
410what are supposed to be temporary devices. The largest
effort to examine retrievability to date was a multicenter
review coordinated by the American Association for the
Surgery of Trauma (AAST).10 Among the observations
from this study was the fact that most R-IVCFs were never
actually retrieved, with a distressingly high percentage (up
to 44%) left in place simply due to lack of follow-up. The
final recommendations included that practice patterns of
R-IVCF insertion and retrieval be re-examined, with em-
phasis placed on improved follow-up.
Civilian trauma patients are a transient population and
difficult to follow, but United States casualties injured in
combat are closely followed in a centralized military health
care system. We hypothesized that we could better charac-
terize R-IVCFs used in trauma with more complete follow-
up. Our objective was to analyze our practice patterns,
outcomes, complications, and retrievability of R-IVCFs in
military war-wounded patients and compare these results to
the existing available civilian data.
METHODS
This was a retrospective review of a prospectively col-
lected trauma registry. United States service-members in-
jured in Iraq and Afghanistan and evacuated toWalter Reed
Army Medical Center in Washington, DC between July 1,
2003 and June 30, 2007 were included. All evaluations for
IVCF insertion were performed by the vascular surgery
service.
Anticoagulation and indications for IVCF. From
battlefield injury to evacuation back to the United States,
each patient is reassessed multiple times for PE and deep
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indications are placed on preventative doses of low-molecular-
weight heparin (LMWH). If present, therapeutic anticoag-
ulation is initiated or, in a very few cases, an IVCF is placed
in-theater.11 Sequential compression devices are always
applied if possible.
Enoxaparin sodium is preferentially used, given as a
subcutaneous injection. Preventative doses are adminis-
tered as 30 mg twice a day or 40 mg daily. Therapeutic
anticoagulation is dosed to 1 mg/kg body weight twice a
day and eventually transitioned to oral warfarin sodium
titrated to an International Normalized Ratio of 2.0-3.0.
IVCF indications were categorized as prophylactic or
therapeutic. Those in the prophylactic group had no evi-
Fig 1. Institutional algorithm used as a referral guide
evaluated for possible IVCF insertion. VTE, venous thr
Coma Scale; LE, lower extremity; AIS, Abbreviated Inju
computed tomographic pulmonary angiography; CTV, C
care unit; SQ, subcutaneous; BID, twice a day.dence of DVT or PE, but were of particularly high riskdespite traditional prevention methods. Sequential com-
pression devices can be difficult to use on those with
multiple amputations or major lower extremity injury with
bulky dressings and external fixation devices. Additionally,
patients may have had relative contraindications to preven-
tative anticoagulation or inability to provide effective anti-
coagulation due to frequent interruptions from multiple
repeat operations.
Patients in the therapeutic group had a documentedDVT
and/or PE and were considered high risk for subsequent PE
or had suffered a complication while anticoagulated. In some
cases, adequate anticoagulation could not be administered
due to frequently required dose interruptions.
Institution-specific guidelines for screening and evalu-
to help determine which military casualties should be
embolism; TBI, traumatic brain injury; GCS, Glasgow
le; CT, computed tomography; US, ultrasound; CTPA,
nography; IVCF, inferior vena cava filter; ICU, intensiveline
ombo
ry Sca
T veation for IVCF were prospectively established at the begin-
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surgeons, vascular surgeons, and intensivists (Fig 1). The
algorithm was based on guidelines set forth by the Eastern
Association for the Surgery of Trauma.12
Demographic, technical, and other data. Demo-
graphics and descriptive data were recorded, including age,
gender, injury mechanism, injury severity score (ISS), and
delay from point of injury to evaluation at our facility.
IVCF insertion technical data included: time interval
between initial injury and filter insertion, procedure site
(main operating room, angiography suite, or bedside),
anatomic route, filter anatomic location after deployment,
filter type and make, and any procedural complications.
Insertions performed in the main operating room or an-
giography suite were done in the traditional manner under
fluoroscopy. For unstable patients in the intensive care unit
(ICU), the IVCF were placed at the bedside under intra-
vascular ultrasound (IVUS) guidance.
Follow-up, complications, and R-IVCF retrieval were the
primary outcomes of interest. Filter-related data included
information on dwell time (interval between insertion and
retrieval), reasons for unsuccessful retrieval attempts, rates of
procedural complications, and reasons for retrievals not at-
tempted. Major complications were defined as: filter migra-
tion or tilt, symptomatic caval occlusion, or breakthrough PE.
Secondary venous thromboembolic events such as PE after
filter removal, DVT at any access site, or asymptomatic caval
occlusion were also examined. Assessments for IVCF migra-
tion, entrapped thrombus, and caval stenosis were done using
caval venography at retrieval (Fig 2).
Results are expressed as mean standard deviation. Biva-
riate analyses were performed using the 2 or Fisher’s exact
test for categorical data. The independent t test was used for
continuous variables. Results were considered statistically sig-
nificant if P  .05. Statistical analyses were performed using
SSPS for Windows 13.0 (SPSS Inc, Chicago, Ill).
Institutional review board approval was obtained prior
to the commencement of this study.
RESULTS
During the 4-year study period there were an estimated
2400 combat-casualty trauma admissions to our stateside
institution. Ninety-one patients received an IVCF (4.0%),
of which 72 were retrievable. Retrievable devices used
included one Recovery (C.R. Bard, Inc, Murray Hill, NJ),
one OptEase (Cordis Corp, Miami Lakes, Fla), and 70
Günther Tulip (Cook, Inc, Bloomington, Ind) filters. Most
patients were men (97%), mean age was 27.4  6.4 years,
and mean ISS was 36.3  10.4. The mechanisms of injury
were blast in 61 (67%), high-velocity gunshot in 20 (22%),
and blunt in 10 (11%).
Fig 2. A, Caval venography was used to examine for filter-
entrapped thrombus, caval stenosis, filter migration (including tilt
14°), strut fracture, or penetration before retrieval. B, Post-pull
images ensured no contrast extravasation or other abnormalities
after retrieval.
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laxis. Twenty-five DVTs and 28 PEs were found in 49 (68%)
patients receiving therapeutic IVCF. Filters were most often
placed in the main operating room (43, 60%) (Fig 3). The
remaining were inserted in the interventional suite (18, 25%)
or at the bedside under IVUS guidance (11, 15%).
The mean delay to IVCF insertion after injury was
12.3  20.4 days. The femoral approach was used in 81
(89%) and a jugular route was used in 10 (11%). There were
two placement-related complications. The first was wire
entanglement during central line placement, which has
been previously reported as a potential occurrence.13 The
second was deployment into an iliac vein early in the
experience of IVUS-guided placements. Both filters were
immediately retrieved and properly replaced without fur-
ther incident.
In the prophylactic group, preventative dose LMWH
was continually ordered in all 23 patients and maintained
through discharge. In the therapeutic group, all were anti-
coagulated prior to their venous thromboembolic event, 48
(98%) on preventative doses and one already receiving the
full therapeutic dose for bilateral DVT. Twenty-seven
(55%) of these were ultimately therapeutically anticoagu-
lated at the time of IVCF placement. The remaining 22
(45%) had temporary contraindications, resulting in a delay
of 11.3  9.3 days (Fig 4), but all 22 were eventually
anticoagulated as well.
In those who received R-IVCF, there were 57 in whom
no retrieval attempt was evermade: 45 of the 72 (63%) were
left in place for ongoing indications, 1 patient died, and 11
did not return for follow-up. Nine of these 11 were trans-
ferred to continue long-term care at non-Department of
Defense medical institutions near their hometowns.
Thirteen of 15 retrieval attempts were successful.
Therefore, overall retrieval rate was 18% and technical
Fig 3. Location of inferior vena cava filter insertions for high-risk
combat-injured military trauma patients. * Intensive care unit/
intravascular ultrasound (ICU/IVUS) refers to critically injured
soldiers that required filter placement at the bedside in the inten-
sive care unit under intravascular ultrasound guidance.retrieval failure was 2.8%. Based on original indications,there were no statistically significant differences in retrieval
attempt rates (prophylactic 17%, therapeutic 22%, P
.437) or procedural success (prophylactic  100%, thera-
peutic  82%, P  .542), see Table I. Both technical
failures were due to filter incorporation into the caval wall,
observed at 90 and 156 days after placement. Median filter
dwell time of those removed was 47 days (range, 10-94).
There were no major R-IVCF complications (migra-
tion, tilt, caval occlusion, or breakthrough PE). There were
also no cases of technical failure due to entrapped thrombus
or caval stenosis. Patients were routinely studied via lower
49 with new DVT or PE 
27 anticoagulated first
22 IVCF 
without anticoagulation
Delay 11.3 ± 9.3 days IVCF
49 fully anticoagulated
1 patient,
fully anticoagulated for 
bilateral DVT
48 patients,
on preventative LMWH
Fig 4. Anticoagulation patterns in those receiving therapeutic
retrievable inferior vena cava filter (IVCF). Preventative dose low
molecular-weight heparin (LMWH) is defined as enoxaparin so-
dium injected subcutaneously dosed at either 30 mg twice a day or
40mg once a day. Full anticoagulation is defined as treatment with
enoxaparin sodium at 1 mg/kg-body-weight twice a day or oral
warfarin sodium titrated to International Normalized Ratio (INR)
value of 2.0 to 3.0. If a gap occurred, the delay in treatment is
expressed in mean standard deviation (in days). DVT, deep vein
thrombosis; PE, pulmonary embolism.
Table I. Comparisons of two groups of patients who
received retrievable filters, by indication
Characteristic
Prophylactic
(n  23)
Therapeutic
(n  49) P value
ISS* 31.8  6.7 37.2  11.4 .04
Age 26.7  5.4 27.1  6.0 .776
Placed at bedside 3 (13.0%) 8 (16.3%) .508
Retrieval, attempts 4 (17.4%) 11 (22.4%) .437
Retrieval, technical
success 4 of 4 (100%) 9 of 11 (82%) .524
Days after injury IVCF
placed* 8.5  5.2 13.8  26.1 .205
Dwell time, in days
‡
53.3  30.1 44.0  24.5 .611
ISS, Injury Severity Score; IVCF, inferior vena cava filter.
*Given in mean  standard deviation.
‡Assumes successful retrieval, given in mean  standard deviation.extremity duplex prior to retrieval to check for DVT, and
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days (28.0  12.0 months) in 61 patients, and no patient
has had a PE after R-IVCF removal.
DISCUSSION
American soldiers wounded in current combat opera-
tions have a 90% survival,14 the highest in major warfare. A
sophisticated trauma system has been developed that em-
phasizes forward treatment and rapid evacuation to the
required level of care.15 Secure worldwide access to elec-
tronic medical records allows real-time communication of
important clinical information regarding injured evacuees.
The ability to follow our patients globally has been the key
to our 85% intact follow-up rate. Our 15% follow-up loss
was significantly lower than seen in the civilian sector (126
of 413, 31%, P  .006),10 giving us the opportunity to
examine retrieval patterns in trauma patients over a longer
term.
We found that despite excellent follow-up, a majority
of retrievable filters were still not actually retrieved. A
comparison of our results to the findings of the AAST
review of civilian trauma is summarized in Table II. Being
able to follow patients more effectively allowed us to dem-
onstrate that a significant proportion of non-retrievals were
due to ongoing indications rather than other reasons such
as inability to anticoagulate or patient refusal.
Our technical failure rate was statistically no different
from existing data on Günther Tulip filters, (2 of 15 [13%]
vs 5 of 54 [10%],10 P  .644), given similar dwell times.
However, we note that both technical failures were due to
incorporation with the caval wall at longer dwell times. A
recent study of R-IVCF in multiple trauma patients sug-
gested that retrieval after dwell times of180 days was safe
and 76% successful in patients who were ambulatory, could
be anticoagulated, and had filter tilt 25 degrees.16 We
have not yet accumulated enough data on late retrieval
Table II. Practice patterns in military trauma patients com
use in civilian trauma patients
Characteristic
Ka
Percentage of R-IVCF in which retrieval attempted
Retrieval technical success
Median dwell time (in days)
Major filter complications
Mean Injury Severity Scorec
R-IVCF left purposefully for ongoing indications
R-IVCF non-retrieval due to loss to follow-up
Percentage R-IVCF managed by vascular surgeons
Patients included in follow-up
Follow-up time (months)c
Overall retrieval rate
AAST, American Association for the Surgery of Trauma; WRAMC, Walter
a2 or Fisher’s exact test.
bt test.
cGiven in mean  standard deviation.attempts to comment.Since PE is the third leading cause of death in patients
who survive 24 hours after trauma,17,18 screening, preven-
tion, and treatment are of particular interest in the military
trauma setting. The delay from injury to stateside evacua-
tion has consistently been about 8 days.19,20 It should be
pointed out that a majority of our indications were thera-
peutic, meaning a DVT or PE may not have developed or
manifested themselves early in the first week. Further, rapid
mass casualty evacuations can lead to situations where
injuries are initially missed and/or subsequently develop.
Analysis in this report is limited to R-IVCF placed after evac-
uation to our stateside institution, and excludes any consider-
ation of filters inserted in a forward military hospital.
Most of the R-IVCF we used were Günther Tulips,
which have previously been shown to have good perfor-
mance profiles with low rates of major complications.21 It
was interesting, however, that there were no other detected
insertion site or de novo DVT. This has been estimated to
occur in 3 to 40% of patients after IVCF placement,22-25
but the etiology and subsequent clinical significance are
unclear. These observations were made in mixed popula-
tions who may have had other risk factors for DVT,22 and a
majority were actually found bilaterally or in the contralat-
eral lower extremity,23 calling into question the direct
relationship between the two events.
We speculate that concurrent anticoagulation plays a
larger role than recognized in the development of throm-
boembolic complications. In the AAST review, it was re-
ported that there was no detectable difference in the rate of
new DVT in those who received anticoagulation after filter
placement vs those who had not.10 However, this was only
a subset analysis of 95 out of 310 prophylaxis patients who
had a subsequent duplex study. This also combined data
from centers that had formal follow-up screening protocols
and those that did not. Therefore, some duplex studies may
have been ordered for clinically apparent indications while
d with the best available multicenter review of R-IVCF
ones et al (AAST),10
n  446
WRAMC,
n  72 P value
26% 21% .292a
78% 87% .478a
44 47 .657b
2% 0% .197a
25.3  12.9 36.3  10.4 .021b
34% 63% .0001a
31% 11% .043a
11% 100% .0001a
51% 85% .001a
5.7  4.3 28.0  12.0 .0001b
20% 18% .435a
Army Medical Center; R-IVCF, retrievable inferior vena cava filter.pare
rmy-J
Reedat the same time the true rate of clinically occult DVT may
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of the 18 new DVTs found (laterality of which were not
specified), 16 (89%) were in those who did not receive any
anticoagulation after filter placement. Moreover, the type,
timing, and duration of anticoagulation used were not
identified.
Decousus et al26 compared trauma patients receiving
anticoagulation alone or IVCF without anticoagulation,
and found a higher rate of recurrent DVT at 2 years in the
IVCF-only group (20.8% vs 11.6%, P  .02). While this
prompted some to advocate the use of anticoagulation with
IVCF as soon as possible to reduce the risk of new DVT,
there was no actual data on those rates in patients who
received both.
Every patient in our series received anticoagulation at
some point, either in preventative or full therapeutic doses.
Those in the therapeutic IVCF group were all transitioned
to full anticoagulation in about 11 days, while in the
prophylaxis group none required sustained interruptions.
This points to the fact that they had complex injuries
making prevention via an anticoagulant inadequate rather
than contraindicated. The fact that 100%of our patientswere
ultimately anticoagulated may help explain the lack of ob-
served filter-related or distant thromboembolic complica-
tions.
Our institution does not have a routine post-IVCF
placement lower-extremity duplex screening protocol. Im-
aging is reserved for those with clinically suspicious symp-
toms suggesting DVT and routinely prior to a R-IVCF
retrieval attempt. Therefore, the true denominator of oc-
cult DVT may still have been missed, but without apparent
clinical consequences.
In summary, compared to the best available civilian
trauma data, review of our practice patterns of R-IVCF use
in military combat-wounded casualties demonstrated no
statistically significant differences in our rates of IVCF
retrieval attempts, technical procedural success, overall re-
trieval rates, or dwell times. R-IVCFs were more often
placed by vascular surgeons in the main operating room.
They were used in patients with high ISS, with minimal
short-term morbidity, and with no observed major filter
complications. When attempted, retrieval was uniformly suc-
cessful when dwell time was less than 90 days. All of our
patients were given anticoagulants, which resulted in no ob-
served cases ofDVT, PE, or caval occlusion.Despitemarkedly
improved follow-up, retrieval rates remained low, left in place
due to ongoing need rather than lost to follow-up.
Diligent follow-up allows interval reassessment and R-
IVCF management decision-making. But given that retrieval
remained low despite excellent follow-up, guidelines for R-
IVCF use in trauma patients for high-risk prophylaxis may
indeed need to be re-evaluated. Prospective trials are needed
to better examine the role of anticoagulation in this setting.
Management should be targeted to either eventual retrieval of
these temporary devices or exchange for a permanent filter as
soon as a permanent indication is identified.AUTHOR CONTRIBUTIONS
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Dr J. Goff (Albuquerque, NM). You had a fairly long delay
from the time that the patients were initially injured to the time
that they received their filter, the average was 8 days. As a former
military surgeon, I know that no injured soldier goes directly to
Walter Reed, they go someplace else first, usually through Land-
stuhl. Explain to us why those filters were either not placed in
country or were not placed where they first landed.
If your rate of recurrent subsequent thromboembolic events is
so low and your filters are being placed so late in the process, it begs
the question, why you’re placing somany and not taking them out.
Dr Johnson. Well, it’s an interesting point and it’s a great
question. And I know that VTE prophylaxis is very strongly
emphasized along every step of the evacuation chain as has been
discussed previously.
All of our patients were evaluated at Walter Reed with a
median delay of 8 days and received their filters here. There are a
certain number of patients that do get filters placed either far
forward in Iraq or at the Regional Medical Center in Landstuhl.
We didn’t include those patients in this particular analysis. But I
don’t have the data to tell you why some patients got them forward
and why some of them got them after 8 days.
In response to the second statement, the lack of subsequent
thromboembolic events, there may be a difference in the antico-
agulation profile of our patients. A lot of papers that are out there,
when they do quote anticoagulation that was given along with theposed to our patients where all of them were eventually anticoag-
ulated, a minority with a small delay.
I think this reflects the fact that our patients didn’t necessarily
have contraindications to anticoagulation per se, or a complication
while on anticoagulation. Rather, with multiple injuries requiring
frequent trips to the operating room every other day, frequent
interruptions in anticoagulation, multiple amputations, bulky casts
or dressings or external fixators that made traditional VTE prophy-
laxis untenable.
DrR. Zwolak (Lebanon, NH). It seems to me the question of
whether or not to retrieve a filter is still on the table. The question
is whether the risks of filter removal are any less than the risks of
leaving it in place. Does your data help us sort that out?
Dr Johnson. Well, our data doesn’t necessarily answer the
question of what should ultimately be done. It definitely tells us
that something needs to be reevaluated, for sure. The strength of
our paper is that in this trauma population, where in the civilian
world it would be very difficult to obtain 88% follow-up at 2-1/2
years, I think we’ve pretty much demonstrated and answered the
AAST’s question that even if you follow trauma patients out for a
long period of time, “retrievable” filters are not actually being
retrieved at a very high rate, and is the right thing really being
done.
I think the question needs to be asked: Are there independent
predictors that can tell when a permanent indication would call for
a permanent filter up front, or whether there is a role for interval
repositioning or some other type of management strategy?
